nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—HTR2A—myenteric nerve plexus—stomach cancer	0.038	0.253	CbGeAlD
Cyclobenzaprine—HTR2A—vagus nerve—stomach cancer	0.0253	0.168	CbGeAlD
Cyclobenzaprine—HTR2A—vein—stomach cancer	0.0245	0.163	CbGeAlD
Cyclobenzaprine—CYP1A2—Fluorouracil—stomach cancer	0.00869	0.369	CbGbCtD
Cyclobenzaprine—HTR2A—blood vessel—stomach cancer	0.00776	0.0516	CbGeAlD
Cyclobenzaprine—CYP1A2—hematopoietic system—stomach cancer	0.00529	0.0352	CbGeAlD
Cyclobenzaprine—CYP3A4—Irinotecan—stomach cancer	0.00474	0.201	CbGbCtD
Cyclobenzaprine—HTR2A—hematopoietic system—stomach cancer	0.00413	0.0275	CbGeAlD
Cyclobenzaprine—CYP2D6—Doxorubicin—stomach cancer	0.00408	0.173	CbGbCtD
Cyclobenzaprine—CYP3A4—hematopoietic system—stomach cancer	0.00383	0.0255	CbGeAlD
Cyclobenzaprine—HTR2A—epithelium—stomach cancer	0.00378	0.0251	CbGeAlD
Cyclobenzaprine—CYP2D6—hematopoietic system—stomach cancer	0.00377	0.025	CbGeAlD
Cyclobenzaprine—CYP1A2—digestive system—stomach cancer	0.00368	0.0245	CbGeAlD
Cyclobenzaprine—HTR2A—smooth muscle tissue—stomach cancer	0.00364	0.0242	CbGeAlD
Cyclobenzaprine—CYP3A4—Docetaxel—stomach cancer	0.00348	0.148	CbGbCtD
Cyclobenzaprine—Promethazine—HRH4—stomach cancer	0.00313	0.194	CrCbGaD
Cyclobenzaprine—Doxepin—HRH4—stomach cancer	0.0031	0.192	CrCbGaD
Cyclobenzaprine—CYP1A2—endocrine gland—stomach cancer	0.00304	0.0202	CbGeAlD
Cyclobenzaprine—HTR2A—digestive system—stomach cancer	0.00288	0.0191	CbGeAlD
Cyclobenzaprine—CYP1A2—liver—stomach cancer	0.00274	0.0182	CbGeAlD
Cyclobenzaprine—CYP3A4—digestive system—stomach cancer	0.00266	0.0177	CbGeAlD
Cyclobenzaprine—CYP2D6—digestive system—stomach cancer	0.00262	0.0174	CbGeAlD
Cyclobenzaprine—CYP3A4—Doxorubicin—stomach cancer	0.00259	0.11	CbGbCtD
Cyclobenzaprine—Amitriptyline—HRH4—stomach cancer	0.0024	0.149	CrCbGaD
Cyclobenzaprine—HTR2A—endocrine gland—stomach cancer	0.00238	0.0158	CbGeAlD
Cyclobenzaprine—CYP3A4—endocrine gland—stomach cancer	0.0022	0.0146	CbGeAlD
Cyclobenzaprine—CYP2D6—endocrine gland—stomach cancer	0.00216	0.0144	CbGeAlD
Cyclobenzaprine—HTR2A—liver—stomach cancer	0.00214	0.0142	CbGeAlD
Cyclobenzaprine—CYP3A4—liver—stomach cancer	0.00198	0.0132	CbGeAlD
Cyclobenzaprine—CYP2D6—liver—stomach cancer	0.00195	0.013	CbGeAlD
Cyclobenzaprine—Cyproheptadine—HTR1A—stomach cancer	0.00147	0.0914	CrCbGaD
Cyclobenzaprine—Tamoxifen—CYP2A6—stomach cancer	0.00103	0.0641	CrCbGaD
Cyclobenzaprine—Nortriptyline—HTR1A—stomach cancer	0.000998	0.0619	CrCbGaD
Cyclobenzaprine—Dry mouth—Docetaxel—stomach cancer	0.000986	0.00128	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000986	0.00128	CcSEcCtD
Cyclobenzaprine—Hepatitis—Methotrexate—stomach cancer	0.000981	0.00128	CcSEcCtD
Cyclobenzaprine—Sweating—Epirubicin—stomach cancer	0.00098	0.00128	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Doxorubicin—stomach cancer	0.00098	0.00128	CcSEcCtD
Cyclobenzaprine—Chest pain—Capecitabine—stomach cancer	0.000976	0.00127	CcSEcCtD
Cyclobenzaprine—Myalgia—Capecitabine—stomach cancer	0.000976	0.00127	CcSEcCtD
Cyclobenzaprine—Confusional state—Docetaxel—stomach cancer	0.000975	0.00127	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Methotrexate—stomach cancer	0.000973	0.00127	CcSEcCtD
Cyclobenzaprine—Anxiety—Capecitabine—stomach cancer	0.000973	0.00127	CcSEcCtD
Cyclobenzaprine—Oedema—Docetaxel—stomach cancer	0.000967	0.00126	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Docetaxel—stomach cancer	0.000967	0.00126	CcSEcCtD
Cyclobenzaprine—Weight increased—Doxorubicin—stomach cancer	0.000965	0.00126	CcSEcCtD
Cyclobenzaprine—Discomfort—Capecitabine—stomach cancer	0.000965	0.00126	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Irinotecan—stomach cancer	0.000957	0.00125	CcSEcCtD
Cyclobenzaprine—Dry mouth—Capecitabine—stomach cancer	0.000955	0.00124	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Epirubicin—stomach cancer	0.000954	0.00124	CcSEcCtD
Cyclobenzaprine—Shock—Docetaxel—stomach cancer	0.000951	0.00124	CcSEcCtD
Cyclobenzaprine—Pruritus—Fluorouracil—stomach cancer	0.000947	0.00123	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Docetaxel—stomach cancer	0.000946	0.00123	CcSEcCtD
Cyclobenzaprine—Drowsiness—Doxorubicin—stomach cancer	0.000946	0.00123	CcSEcCtD
Cyclobenzaprine—Confusional state—Capecitabine—stomach cancer	0.000944	0.00123	CcSEcCtD
Cyclobenzaprine—Tachycardia—Docetaxel—stomach cancer	0.000943	0.00123	CcSEcCtD
Cyclobenzaprine—Trimipramine—HTR1A—stomach cancer	0.00094	0.0583	CrCbGaD
Cyclobenzaprine—Oedema—Capecitabine—stomach cancer	0.000936	0.00122	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000927	0.00121	CcSEcCtD
Cyclobenzaprine—Dizziness—Irinotecan—stomach cancer	0.000925	0.0012	CcSEcCtD
Cyclobenzaprine—Stomatitis—Doxorubicin—stomach cancer	0.000922	0.0012	CcSEcCtD
Cyclobenzaprine—Jaundice—Doxorubicin—stomach cancer	0.000922	0.0012	CcSEcCtD
Cyclobenzaprine—Anorexia—Docetaxel—stomach cancer	0.000921	0.0012	CcSEcCtD
Cyclobenzaprine—Shock—Capecitabine—stomach cancer	0.000921	0.0012	CcSEcCtD
Cyclobenzaprine—Hepatitis—Epirubicin—stomach cancer	0.000918	0.00119	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Fluorouracil—stomach cancer	0.000916	0.00119	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Capecitabine—stomach cancer	0.000916	0.00119	CcSEcCtD
Cyclobenzaprine—Tinnitus—Methotrexate—stomach cancer	0.000914	0.00119	CcSEcCtD
Cyclobenzaprine—Tachycardia—Capecitabine—stomach cancer	0.000913	0.00119	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Epirubicin—stomach cancer	0.000913	0.00119	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Epirubicin—stomach cancer	0.000911	0.00119	CcSEcCtD
Cyclobenzaprine—Sweating—Doxorubicin—stomach cancer	0.000907	0.00118	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Capecitabine—stomach cancer	0.000905	0.00118	CcSEcCtD
Cyclobenzaprine—Hypotension—Docetaxel—stomach cancer	0.000903	0.00118	CcSEcCtD
Cyclobenzaprine—Doxepin—HTR1A—stomach cancer	0.000896	0.0556	CrCbGaD
Cyclobenzaprine—Anorexia—Capecitabine—stomach cancer	0.000892	0.00116	CcSEcCtD
Cyclobenzaprine—Vomiting—Irinotecan—stomach cancer	0.000889	0.00116	CcSEcCtD
Cyclobenzaprine—Dizziness—Fluorouracil—stomach cancer	0.000886	0.00115	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Doxorubicin—stomach cancer	0.000883	0.00115	CcSEcCtD
Cyclobenzaprine—Rash—Irinotecan—stomach cancer	0.000882	0.00115	CcSEcCtD
Cyclobenzaprine—Dermatitis—Irinotecan—stomach cancer	0.000881	0.00115	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000881	0.00115	CcSEcCtD
Cyclobenzaprine—Headache—Irinotecan—stomach cancer	0.000876	0.00114	CcSEcCtD
Cyclobenzaprine—Hypotension—Capecitabine—stomach cancer	0.000874	0.00114	CcSEcCtD
Cyclobenzaprine—Insomnia—Docetaxel—stomach cancer	0.000874	0.00114	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Docetaxel—stomach cancer	0.000868	0.00113	CcSEcCtD
Cyclobenzaprine—Alopecia—Methotrexate—stomach cancer	0.000867	0.00113	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Docetaxel—stomach cancer	0.000862	0.00112	CcSEcCtD
Cyclobenzaprine—Somnolence—Docetaxel—stomach cancer	0.000859	0.00112	CcSEcCtD
Cyclobenzaprine—Tinnitus—Epirubicin—stomach cancer	0.000856	0.00111	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000853	0.00111	CcSEcCtD
Cyclobenzaprine—Vomiting—Fluorouracil—stomach cancer	0.000851	0.00111	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Docetaxel—stomach cancer	0.000851	0.00111	CcSEcCtD
Cyclobenzaprine—Hepatitis—Doxorubicin—stomach cancer	0.000849	0.00111	CcSEcCtD
Cyclobenzaprine—Insomnia—Capecitabine—stomach cancer	0.000846	0.0011	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000845	0.0011	CcSEcCtD
Cyclobenzaprine—Rash—Fluorouracil—stomach cancer	0.000844	0.0011	CcSEcCtD
Cyclobenzaprine—Dermatitis—Fluorouracil—stomach cancer	0.000844	0.0011	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Doxorubicin—stomach cancer	0.000843	0.0011	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Capecitabine—stomach cancer	0.00084	0.00109	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Docetaxel—stomach cancer	0.00084	0.00109	CcSEcCtD
Cyclobenzaprine—Headache—Fluorouracil—stomach cancer	0.000839	0.00109	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Methotrexate—stomach cancer	0.000836	0.00109	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Capecitabine—stomach cancer	0.000834	0.00109	CcSEcCtD
Cyclobenzaprine—Fatigue—Docetaxel—stomach cancer	0.000833	0.00108	CcSEcCtD
Cyclobenzaprine—Nausea—Irinotecan—stomach cancer	0.000831	0.00108	CcSEcCtD
Cyclobenzaprine—Constipation—Docetaxel—stomach cancer	0.000827	0.00108	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Capecitabine—stomach cancer	0.000824	0.00107	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Epirubicin—stomach cancer	0.00082	0.00107	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Capecitabine—stomach cancer	0.000814	0.00106	CcSEcCtD
Cyclobenzaprine—Alopecia—Epirubicin—stomach cancer	0.000811	0.00106	CcSEcCtD
Cyclobenzaprine—Fatigue—Capecitabine—stomach cancer	0.000807	0.00105	CcSEcCtD
Cyclobenzaprine—Vision blurred—Methotrexate—stomach cancer	0.000804	0.00105	CcSEcCtD
Cyclobenzaprine—Constipation—Capecitabine—stomach cancer	0.0008	0.00104	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Docetaxel—stomach cancer	0.000797	0.00104	CcSEcCtD
Cyclobenzaprine—Nausea—Fluorouracil—stomach cancer	0.000795	0.00104	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Methotrexate—stomach cancer	0.000792	0.00103	CcSEcCtD
Cyclobenzaprine—Tinnitus—Doxorubicin—stomach cancer	0.000792	0.00103	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Docetaxel—stomach cancer	0.00079	0.00103	CcSEcCtD
Cyclobenzaprine—Flatulence—Epirubicin—stomach cancer	0.000787	0.00102	CcSEcCtD
Cyclobenzaprine—Tension—Epirubicin—stomach cancer	0.000784	0.00102	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Epirubicin—stomach cancer	0.000782	0.00102	CcSEcCtD
Cyclobenzaprine—Nervousness—Epirubicin—stomach cancer	0.000776	0.00101	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Capecitabine—stomach cancer	0.000771	0.001	CcSEcCtD
Cyclobenzaprine—Malaise—Methotrexate—stomach cancer	0.00077	0.001	CcSEcCtD
Cyclobenzaprine—Vertigo—Methotrexate—stomach cancer	0.000767	0.000998	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000765	0.000996	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Docetaxel—stomach cancer	0.000764	0.000995	CcSEcCtD
Cyclobenzaprine—Leukopenia—Methotrexate—stomach cancer	0.000764	0.000995	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Doxorubicin—stomach cancer	0.000759	0.000987	CcSEcCtD
Cyclobenzaprine—Vision blurred—Epirubicin—stomach cancer	0.000753	0.00098	CcSEcCtD
Cyclobenzaprine—Alopecia—Doxorubicin—stomach cancer	0.00075	0.000977	CcSEcCtD
Cyclobenzaprine—Urticaria—Capecitabine—stomach cancer	0.000743	0.000968	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Epirubicin—stomach cancer	0.000741	0.000965	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Capecitabine—stomach cancer	0.00074	0.000963	CcSEcCtD
Cyclobenzaprine—Convulsion—Methotrexate—stomach cancer	0.00074	0.000963	CcSEcCtD
Cyclobenzaprine—Agitation—Epirubicin—stomach cancer	0.000734	0.000956	CcSEcCtD
Cyclobenzaprine—Flatulence—Doxorubicin—stomach cancer	0.000728	0.000948	CcSEcCtD
Cyclobenzaprine—Myalgia—Methotrexate—stomach cancer	0.000727	0.000946	CcSEcCtD
Cyclobenzaprine—Chest pain—Methotrexate—stomach cancer	0.000727	0.000946	CcSEcCtD
Cyclobenzaprine—Tension—Doxorubicin—stomach cancer	0.000725	0.000944	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Doxorubicin—stomach cancer	0.000724	0.000942	CcSEcCtD
Cyclobenzaprine—Malaise—Epirubicin—stomach cancer	0.00072	0.000938	CcSEcCtD
Cyclobenzaprine—Discomfort—Methotrexate—stomach cancer	0.000718	0.000935	CcSEcCtD
Cyclobenzaprine—Nervousness—Doxorubicin—stomach cancer	0.000718	0.000934	CcSEcCtD
Cyclobenzaprine—Vertigo—Epirubicin—stomach cancer	0.000718	0.000934	CcSEcCtD
Cyclobenzaprine—Syncope—Epirubicin—stomach cancer	0.000716	0.000932	CcSEcCtD
Cyclobenzaprine—Leukopenia—Epirubicin—stomach cancer	0.000715	0.000931	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Docetaxel—stomach cancer	0.000712	0.000927	CcSEcCtD
Cyclobenzaprine—Palpitations—Epirubicin—stomach cancer	0.000706	0.000919	CcSEcCtD
Cyclobenzaprine—Confusional state—Methotrexate—stomach cancer	0.000702	0.000914	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Epirubicin—stomach cancer	0.000702	0.000914	CcSEcCtD
Cyclobenzaprine—Imipramine—HTR1A—stomach cancer	0.000697	0.0432	CrCbGaD
Cyclobenzaprine—Anaphylactic shock—Methotrexate—stomach cancer	0.000697	0.000907	CcSEcCtD
Cyclobenzaprine—Vision blurred—Doxorubicin—stomach cancer	0.000697	0.000907	CcSEcCtD
Cyclobenzaprine—Asthenia—Docetaxel—stomach cancer	0.000694	0.000903	CcSEcCtD
Cyclobenzaprine—Amitriptyline—HTR1A—stomach cancer	0.000693	0.043	CrCbGaD
Cyclobenzaprine—Convulsion—Epirubicin—stomach cancer	0.000692	0.000901	CcSEcCtD
Cyclobenzaprine—Hypertension—Epirubicin—stomach cancer	0.00069	0.000898	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Capecitabine—stomach cancer	0.000689	0.000897	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000686	0.000893	CcSEcCtD
Cyclobenzaprine—Pruritus—Docetaxel—stomach cancer	0.000684	0.00089	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Methotrexate—stomach cancer	0.000682	0.000888	CcSEcCtD
Cyclobenzaprine—Chest pain—Epirubicin—stomach cancer	0.00068	0.000885	CcSEcCtD
Cyclobenzaprine—Myalgia—Epirubicin—stomach cancer	0.00068	0.000885	CcSEcCtD
Cyclobenzaprine—Agitation—Doxorubicin—stomach cancer	0.000679	0.000884	CcSEcCtD
Cyclobenzaprine—Anxiety—Epirubicin—stomach cancer	0.000678	0.000882	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methotrexate—stomach cancer	0.000673	0.000877	CcSEcCtD
Cyclobenzaprine—Discomfort—Epirubicin—stomach cancer	0.000672	0.000875	CcSEcCtD
Cyclobenzaprine—Asthenia—Capecitabine—stomach cancer	0.000671	0.000874	CcSEcCtD
Cyclobenzaprine—Malaise—Doxorubicin—stomach cancer	0.000667	0.000868	CcSEcCtD
Cyclobenzaprine—Dry mouth—Epirubicin—stomach cancer	0.000665	0.000866	CcSEcCtD
Cyclobenzaprine—Vertigo—Doxorubicin—stomach cancer	0.000664	0.000864	CcSEcCtD
Cyclobenzaprine—Anorexia—Methotrexate—stomach cancer	0.000664	0.000864	CcSEcCtD
Cyclobenzaprine—Syncope—Doxorubicin—stomach cancer	0.000663	0.000863	CcSEcCtD
Cyclobenzaprine—Pruritus—Capecitabine—stomach cancer	0.000662	0.000862	CcSEcCtD
Cyclobenzaprine—Leukopenia—Doxorubicin—stomach cancer	0.000662	0.000861	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Docetaxel—stomach cancer	0.000661	0.000861	CcSEcCtD
Cyclobenzaprine—Confusional state—Epirubicin—stomach cancer	0.000657	0.000856	CcSEcCtD
Cyclobenzaprine—Palpitations—Doxorubicin—stomach cancer	0.000653	0.00085	CcSEcCtD
Cyclobenzaprine—Oedema—Epirubicin—stomach cancer	0.000652	0.000849	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Epirubicin—stomach cancer	0.000652	0.000849	CcSEcCtD
Cyclobenzaprine—Hypotension—Methotrexate—stomach cancer	0.000651	0.000847	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Doxorubicin—stomach cancer	0.00065	0.000846	CcSEcCtD
Cyclobenzaprine—Shock—Epirubicin—stomach cancer	0.000641	0.000835	CcSEcCtD
Cyclobenzaprine—Convulsion—Doxorubicin—stomach cancer	0.00064	0.000834	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Capecitabine—stomach cancer	0.00064	0.000833	CcSEcCtD
Cyclobenzaprine—Dizziness—Docetaxel—stomach cancer	0.000639	0.000832	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Epirubicin—stomach cancer	0.000638	0.000831	CcSEcCtD
Cyclobenzaprine—Hypertension—Doxorubicin—stomach cancer	0.000638	0.000831	CcSEcCtD
Cyclobenzaprine—Tachycardia—Epirubicin—stomach cancer	0.000636	0.000828	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000635	0.000826	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Epirubicin—stomach cancer	0.00063	0.00082	CcSEcCtD
Cyclobenzaprine—Insomnia—Methotrexate—stomach cancer	0.00063	0.00082	CcSEcCtD
Cyclobenzaprine—Myalgia—Doxorubicin—stomach cancer	0.000629	0.000819	CcSEcCtD
Cyclobenzaprine—Chest pain—Doxorubicin—stomach cancer	0.000629	0.000819	CcSEcCtD
Cyclobenzaprine—Anxiety—Doxorubicin—stomach cancer	0.000627	0.000816	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methotrexate—stomach cancer	0.000626	0.000814	CcSEcCtD
Cyclobenzaprine—Discomfort—Doxorubicin—stomach cancer	0.000622	0.000809	CcSEcCtD
Cyclobenzaprine—Anorexia—Epirubicin—stomach cancer	0.000621	0.000809	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Methotrexate—stomach cancer	0.000621	0.000808	CcSEcCtD
Cyclobenzaprine—Somnolence—Methotrexate—stomach cancer	0.000619	0.000806	CcSEcCtD
Cyclobenzaprine—Dizziness—Capecitabine—stomach cancer	0.000619	0.000805	CcSEcCtD
Cyclobenzaprine—Dry mouth—Doxorubicin—stomach cancer	0.000615	0.000801	CcSEcCtD
Cyclobenzaprine—Vomiting—Docetaxel—stomach cancer	0.000615	0.0008	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methotrexate—stomach cancer	0.000613	0.000798	CcSEcCtD
Cyclobenzaprine—Rash—Docetaxel—stomach cancer	0.000609	0.000793	CcSEcCtD
Cyclobenzaprine—Hypotension—Epirubicin—stomach cancer	0.000609	0.000793	CcSEcCtD
Cyclobenzaprine—Dermatitis—Docetaxel—stomach cancer	0.000609	0.000793	CcSEcCtD
Cyclobenzaprine—Confusional state—Doxorubicin—stomach cancer	0.000608	0.000792	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Methotrexate—stomach cancer	0.000606	0.000788	CcSEcCtD
Cyclobenzaprine—Headache—Docetaxel—stomach cancer	0.000606	0.000788	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000603	0.000785	CcSEcCtD
Cyclobenzaprine—Oedema—Doxorubicin—stomach cancer	0.000603	0.000785	CcSEcCtD
Cyclobenzaprine—Fatigue—Methotrexate—stomach cancer	0.000601	0.000782	CcSEcCtD
Cyclobenzaprine—Vomiting—Capecitabine—stomach cancer	0.000595	0.000774	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000594	0.000773	CcSEcCtD
Cyclobenzaprine—Shock—Doxorubicin—stomach cancer	0.000593	0.000772	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000591	0.000769	CcSEcCtD
Cyclobenzaprine—Rash—Capecitabine—stomach cancer	0.00059	0.000768	CcSEcCtD
Cyclobenzaprine—Insomnia—Epirubicin—stomach cancer	0.00059	0.000768	CcSEcCtD
Cyclobenzaprine—Dermatitis—Capecitabine—stomach cancer	0.00059	0.000767	CcSEcCtD
Cyclobenzaprine—Tachycardia—Doxorubicin—stomach cancer	0.000589	0.000766	CcSEcCtD
Cyclobenzaprine—Headache—Capecitabine—stomach cancer	0.000586	0.000763	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Epirubicin—stomach cancer	0.000585	0.000762	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000583	0.000759	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Epirubicin—stomach cancer	0.000581	0.000757	CcSEcCtD
Cyclobenzaprine—Somnolence—Epirubicin—stomach cancer	0.00058	0.000754	CcSEcCtD
Cyclobenzaprine—Anorexia—Doxorubicin—stomach cancer	0.000575	0.000748	CcSEcCtD
Cyclobenzaprine—Nausea—Docetaxel—stomach cancer	0.000574	0.000747	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Methotrexate—stomach cancer	0.000574	0.000747	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Epirubicin—stomach cancer	0.000574	0.000747	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methotrexate—stomach cancer	0.00057	0.000741	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Epirubicin—stomach cancer	0.000567	0.000738	CcSEcCtD
Cyclobenzaprine—Hypotension—Doxorubicin—stomach cancer	0.000564	0.000734	CcSEcCtD
Cyclobenzaprine—Fatigue—Epirubicin—stomach cancer	0.000562	0.000732	CcSEcCtD
Cyclobenzaprine—Constipation—Epirubicin—stomach cancer	0.000558	0.000726	CcSEcCtD
Cyclobenzaprine—Nausea—Capecitabine—stomach cancer	0.000556	0.000724	CcSEcCtD
Cyclobenzaprine—Urticaria—Methotrexate—stomach cancer	0.000553	0.00072	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methotrexate—stomach cancer	0.000551	0.000717	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00055	0.000715	CcSEcCtD
Cyclobenzaprine—Insomnia—Doxorubicin—stomach cancer	0.000546	0.00071	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Doxorubicin—stomach cancer	0.000542	0.000705	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Doxorubicin—stomach cancer	0.000538	0.0007	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Epirubicin—stomach cancer	0.000537	0.000699	CcSEcCtD
Cyclobenzaprine—Somnolence—Doxorubicin—stomach cancer	0.000536	0.000698	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000533	0.000694	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Doxorubicin—stomach cancer	0.000531	0.000691	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Doxorubicin—stomach cancer	0.000524	0.000683	CcSEcCtD
Cyclobenzaprine—Fatigue—Doxorubicin—stomach cancer	0.00052	0.000677	CcSEcCtD
Cyclobenzaprine—Urticaria—Epirubicin—stomach cancer	0.000518	0.000674	CcSEcCtD
Cyclobenzaprine—Constipation—Doxorubicin—stomach cancer	0.000516	0.000671	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Epirubicin—stomach cancer	0.000515	0.000671	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methotrexate—stomach cancer	0.000513	0.000668	CcSEcCtD
Cyclobenzaprine—Asthenia—Methotrexate—stomach cancer	0.0005	0.000651	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Doxorubicin—stomach cancer	0.000497	0.000647	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000493	0.000642	CcSEcCtD
Cyclobenzaprine—Pruritus—Methotrexate—stomach cancer	0.000493	0.000642	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Epirubicin—stomach cancer	0.00048	0.000625	CcSEcCtD
Cyclobenzaprine—Urticaria—Doxorubicin—stomach cancer	0.000479	0.000624	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Doxorubicin—stomach cancer	0.000477	0.000621	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Methotrexate—stomach cancer	0.000477	0.00062	CcSEcCtD
Cyclobenzaprine—Asthenia—Epirubicin—stomach cancer	0.000468	0.000609	CcSEcCtD
Cyclobenzaprine—Pruritus—Epirubicin—stomach cancer	0.000461	0.0006	CcSEcCtD
Cyclobenzaprine—Dizziness—Methotrexate—stomach cancer	0.000461	0.0006	CcSEcCtD
Cyclobenzaprine—Nortriptyline—ALB—stomach cancer	0.000448	0.0278	CrCbGaD
Cyclobenzaprine—Diarrhoea—Epirubicin—stomach cancer	0.000446	0.000581	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Doxorubicin—stomach cancer	0.000444	0.000578	CcSEcCtD
Cyclobenzaprine—Vomiting—Methotrexate—stomach cancer	0.000443	0.000577	CcSEcCtD
Cyclobenzaprine—Rash—Methotrexate—stomach cancer	0.000439	0.000572	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methotrexate—stomach cancer	0.000439	0.000571	CcSEcCtD
Cyclobenzaprine—Headache—Methotrexate—stomach cancer	0.000436	0.000568	CcSEcCtD
Cyclobenzaprine—Asthenia—Doxorubicin—stomach cancer	0.000433	0.000563	CcSEcCtD
Cyclobenzaprine—Dizziness—Epirubicin—stomach cancer	0.000431	0.000561	CcSEcCtD
Cyclobenzaprine—Pruritus—Doxorubicin—stomach cancer	0.000427	0.000556	CcSEcCtD
Cyclobenzaprine—Vomiting—Epirubicin—stomach cancer	0.000415	0.00054	CcSEcCtD
Cyclobenzaprine—Nausea—Methotrexate—stomach cancer	0.000414	0.000539	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Doxorubicin—stomach cancer	0.000413	0.000537	CcSEcCtD
Cyclobenzaprine—Rash—Epirubicin—stomach cancer	0.000411	0.000535	CcSEcCtD
Cyclobenzaprine—Dermatitis—Epirubicin—stomach cancer	0.000411	0.000535	CcSEcCtD
Cyclobenzaprine—Headache—Epirubicin—stomach cancer	0.000408	0.000532	CcSEcCtD
Cyclobenzaprine—Dizziness—Doxorubicin—stomach cancer	0.000399	0.000519	CcSEcCtD
Cyclobenzaprine—Nausea—Epirubicin—stomach cancer	0.000387	0.000504	CcSEcCtD
Cyclobenzaprine—Vomiting—Doxorubicin—stomach cancer	0.000384	0.000499	CcSEcCtD
Cyclobenzaprine—Rash—Doxorubicin—stomach cancer	0.00038	0.000495	CcSEcCtD
Cyclobenzaprine—Dermatitis—Doxorubicin—stomach cancer	0.00038	0.000495	CcSEcCtD
Cyclobenzaprine—Headache—Doxorubicin—stomach cancer	0.000378	0.000492	CcSEcCtD
Cyclobenzaprine—Nausea—Doxorubicin—stomach cancer	0.000358	0.000466	CcSEcCtD
Cyclobenzaprine—Amitriptyline—ALB—stomach cancer	0.000311	0.0193	CrCbGaD
Cyclobenzaprine—CYP2D6—Metabolism—NDUFV1—stomach cancer	4.6e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NDUFS1—stomach cancer	4.6e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GMPR2—stomach cancer	4.59e-05	0.0011	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	4.56e-05	0.00109	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AGTR2—stomach cancer	4.53e-05	0.00109	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TNF—stomach cancer	4.51e-05	0.00108	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—WWOX—stomach cancer	4.5e-05	0.00108	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—F2R—stomach cancer	4.48e-05	0.00108	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	4.43e-05	0.00106	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	4.37e-05	0.00105	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR1A—stomach cancer	4.36e-05	0.00105	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTM1—stomach cancer	4.24e-05	0.00102	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ANXA1—stomach cancer	4.21e-05	0.00101	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SUCLG1—stomach cancer	4.19e-05	0.00101	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—IDH3B—stomach cancer	4.19e-05	0.00101	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	4.19e-05	0.00101	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—WIF1—stomach cancer	4.18e-05	0.001	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HRH4—stomach cancer	4.18e-05	0.001	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AGTR2—stomach cancer	4.11e-05	0.000988	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—BLVRB—stomach cancer	4.1e-05	0.000985	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PGLS—stomach cancer	4.1e-05	0.000985	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADRB1—stomach cancer	4.08e-05	0.000979	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—F2R—stomach cancer	4.07e-05	0.000977	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ACAD8—stomach cancer	3.97e-05	0.000954	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR1A—stomach cancer	3.96e-05	0.000951	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPAP2A—stomach cancer	3.91e-05	0.00094	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NDUFS1—stomach cancer	3.9e-05	0.000936	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NDUFV1—stomach cancer	3.9e-05	0.000936	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRKAB1—stomach cancer	3.86e-05	0.000927	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	3.85e-05	0.000924	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ANXA1—stomach cancer	3.82e-05	0.000918	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	3.81e-05	0.000915	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RNF43—stomach cancer	3.73e-05	0.000895	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KISS1—stomach cancer	3.73e-05	0.000895	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	3.71e-05	0.000891	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADRB1—stomach cancer	3.7e-05	0.000889	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	3.66e-05	0.000879	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	3.66e-05	0.000879	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL6—stomach cancer	3.64e-05	0.000873	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—PIK3CA—stomach cancer	3.55e-05	0.000853	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GMPR2—stomach cancer	3.54e-05	0.00085	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NDUFA2—stomach cancer	3.49e-05	0.000838	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—FBP1—stomach cancer	3.49e-05	0.000838	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CA1—stomach cancer	3.49e-05	0.000838	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CKB—stomach cancer	3.49e-05	0.000838	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PGLS—stomach cancer	3.48e-05	0.000835	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—BLVRB—stomach cancer	3.48e-05	0.000835	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	3.46e-05	0.00083	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FST—stomach cancer	3.32e-05	0.000798	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPAP2A—stomach cancer	3.32e-05	0.000796	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADRB2—stomach cancer	3.3e-05	0.000794	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLIN2—stomach cancer	3.28e-05	0.000788	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HBEGF—stomach cancer	3.25e-05	0.000781	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—IDH3B—stomach cancer	3.24e-05	0.000777	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SUCLG1—stomach cancer	3.24e-05	0.000777	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GAST—stomach cancer	3.21e-05	0.00077	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RGS2—stomach cancer	3.21e-05	0.00077	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CA2—stomach cancer	3.19e-05	0.000766	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	3.19e-05	0.000766	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	3.18e-05	0.000763	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NT5E—stomach cancer	3.11e-05	0.000747	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PGAM1—stomach cancer	3.11e-05	0.000747	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGG—stomach cancer	3.04e-05	0.00073	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NDUFS1—stomach cancer	3.01e-05	0.000723	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NDUFV1—stomach cancer	3.01e-05	0.000723	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADRB2—stomach cancer	3e-05	0.000721	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALDH7A1—stomach cancer	2.97e-05	0.000712	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLCE1—stomach cancer	2.97e-05	0.000712	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—FBP1—stomach cancer	2.96e-05	0.00071	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CKB—stomach cancer	2.96e-05	0.00071	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CA1—stomach cancer	2.96e-05	0.00071	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NDUFA2—stomach cancer	2.96e-05	0.00071	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PPP2R1A—stomach cancer	2.94e-05	0.000706	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	2.94e-05	0.000706	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRKAA1—stomach cancer	2.93e-05	0.000703	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—UMPS—stomach cancer	2.84e-05	0.000683	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RBP4—stomach cancer	2.83e-05	0.000679	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CXCL8—stomach cancer	2.82e-05	0.000678	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	2.81e-05	0.000676	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLIN2—stomach cancer	2.78e-05	0.000667	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CA2—stomach cancer	2.7e-05	0.000649	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PGLS—stomach cancer	2.68e-05	0.000644	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—BLVRB—stomach cancer	2.68e-05	0.000644	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ECHS1—stomach cancer	2.64e-05	0.000635	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PDHA1—stomach cancer	2.64e-05	0.000635	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NT5E—stomach cancer	2.63e-05	0.000633	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PGAM1—stomach cancer	2.63e-05	0.000633	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.56e-05	0.000614	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLCE1—stomach cancer	2.51e-05	0.000603	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALDH7A1—stomach cancer	2.51e-05	0.000603	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TYMP—stomach cancer	2.49e-05	0.000597	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—FADS1—stomach cancer	2.49e-05	0.000597	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HSPB1—stomach cancer	2.43e-05	0.000584	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AGTR2—stomach cancer	2.43e-05	0.000584	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—UMPS—stomach cancer	2.41e-05	0.000579	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—F2R—stomach cancer	2.4e-05	0.000577	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—BMP2—stomach cancer	2.4e-05	0.000577	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKR1C3—stomach cancer	2.36e-05	0.000568	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR1A—stomach cancer	2.34e-05	0.000562	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SREBF2—stomach cancer	2.33e-05	0.000559	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—RORA—stomach cancer	2.3e-05	0.000552	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.28e-05	0.000548	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CKB—stomach cancer	2.28e-05	0.000548	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CA1—stomach cancer	2.28e-05	0.000548	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—FBP1—stomach cancer	2.28e-05	0.000548	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PRKCB—stomach cancer	2.26e-05	0.000544	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ANXA1—stomach cancer	2.26e-05	0.000543	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PDHA1—stomach cancer	2.24e-05	0.000538	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ECHS1—stomach cancer	2.24e-05	0.000538	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRB1—stomach cancer	2.19e-05	0.000525	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALDOB—stomach cancer	2.16e-05	0.000518	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLIN2—stomach cancer	2.14e-05	0.000515	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TYMP—stomach cancer	2.11e-05	0.000506	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—FADS1—stomach cancer	2.11e-05	0.000506	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RPS6—stomach cancer	2.09e-05	0.000502	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CA2—stomach cancer	2.09e-05	0.000501	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PRKCB—stomach cancer	2.06e-05	0.000494	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6ST—stomach cancer	2.05e-05	0.000492	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NT5E—stomach cancer	2.03e-05	0.000488	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PGAM1—stomach cancer	2.03e-05	0.000488	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALOX5—stomach cancer	2e-05	0.000481	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SREBF2—stomach cancer	1.97e-05	0.000474	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—DPYD—stomach cancer	1.97e-05	0.000473	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—RORA—stomach cancer	1.95e-05	0.000468	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.94e-05	0.000466	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLCE1—stomach cancer	1.94e-05	0.000466	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HBEGF—stomach cancer	1.92e-05	0.000461	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—UMPS—stomach cancer	1.86e-05	0.000446	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6R—stomach cancer	1.83e-05	0.000439	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALDOB—stomach cancer	1.83e-05	0.000438	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—RHOA—stomach cancer	1.82e-05	0.000437	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRB2—stomach cancer	1.77e-05	0.000426	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTT1—stomach cancer	1.74e-05	0.000419	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PPP2R1A—stomach cancer	1.74e-05	0.000417	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ECHS1—stomach cancer	1.73e-05	0.000415	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PDHA1—stomach cancer	1.73e-05	0.000415	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.72e-05	0.000414	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.72e-05	0.000413	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.72e-05	0.000412	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALOX5—stomach cancer	1.7e-05	0.000408	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.68e-05	0.000402	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—DPYD—stomach cancer	1.67e-05	0.000401	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—RHOA—stomach cancer	1.65e-05	0.000396	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ENO1—stomach cancer	1.63e-05	0.000392	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TYMP—stomach cancer	1.63e-05	0.00039	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—FADS1—stomach cancer	1.63e-05	0.00039	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SMAD4—stomach cancer	1.61e-05	0.000387	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CXCL8—stomach cancer	1.6e-05	0.000383	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FYN—stomach cancer	1.53e-05	0.000368	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SREBF2—stomach cancer	1.52e-05	0.000365	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.51e-05	0.000363	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—RORA—stomach cancer	1.5e-05	0.000361	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTT1—stomach cancer	1.48e-05	0.000355	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2A6—stomach cancer	1.46e-05	0.00035	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCL8—stomach cancer	1.45e-05	0.000348	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CD44—stomach cancer	1.45e-05	0.000348	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGFR2—stomach cancer	1.44e-05	0.000345	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.42e-05	0.000341	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALDOB—stomach cancer	1.41e-05	0.000338	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ENO1—stomach cancer	1.38e-05	0.000332	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.36e-05	0.000327	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IRS2—stomach cancer	1.32e-05	0.000316	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALOX5—stomach cancer	1.31e-05	0.000315	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—DPYD—stomach cancer	1.29e-05	0.000309	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CAV1—stomach cancer	1.28e-05	0.000307	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOA1—stomach cancer	1.27e-05	0.000306	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.23e-05	0.000296	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CD44—stomach cancer	1.23e-05	0.000295	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRKCB—stomach cancer	1.22e-05	0.000292	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6ST—stomach cancer	1.21e-05	0.000291	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTP1—stomach cancer	1.21e-05	0.00029	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMOX1—stomach cancer	1.19e-05	0.000286	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.19e-05	0.000286	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APC—stomach cancer	1.16e-05	0.000279	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTT1—stomach cancer	1.14e-05	0.000274	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.13e-05	0.000271	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TYMS—stomach cancer	1.12e-05	0.00027	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MAPK3—stomach cancer	1.11e-05	0.000267	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTM1—stomach cancer	1.11e-05	0.000267	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.1e-05	0.000263	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6R—stomach cancer	1.08e-05	0.000259	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ENO1—stomach cancer	1.07e-05	0.000256	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MAPK1—stomach cancer	1.06e-05	0.000254	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EGFR—stomach cancer	1.06e-05	0.000254	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ERCC2—stomach cancer	1.04e-05	0.000251	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	1.04e-05	0.000251	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTP1—stomach cancer	1.02e-05	0.000246	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CA—stomach cancer	1.01e-05	0.000243	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SERPINE1—stomach cancer	1.01e-05	0.000243	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMOX1—stomach cancer	1.01e-05	0.000242	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—KRAS—stomach cancer	1e-05	0.00024	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTHFR—stomach cancer	9.81e-06	0.000236	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RHOA—stomach cancer	9.75e-06	0.000234	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOS3—stomach cancer	9.65e-06	0.000232	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TYMS—stomach cancer	9.52e-06	0.000228	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CD44—stomach cancer	9.47e-06	0.000227	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTM1—stomach cancer	9.41e-06	0.000226	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	9.19e-06	0.000221	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CAV1—stomach cancer	9.05e-06	0.000217	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOA1—stomach cancer	9.03e-06	0.000217	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ERBB2—stomach cancer	9.03e-06	0.000217	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ERCC2—stomach cancer	8.84e-06	0.000212	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCL8—stomach cancer	8.56e-06	0.000206	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HRAS—stomach cancer	8.51e-06	0.000204	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	8.36e-06	0.000201	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTHFR—stomach cancer	8.31e-06	0.0002	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6—stomach cancer	8.14e-06	0.000196	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	8.05e-06	0.000193	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCND1—stomach cancer	7.98e-06	0.000192	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—JUN—stomach cancer	7.96e-06	0.000191	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARG—stomach cancer	7.96e-06	0.000191	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTP1—stomach cancer	7.9e-06	0.00019	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMOX1—stomach cancer	7.79e-06	0.000187	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP9—stomach cancer	7.74e-06	0.000186	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	7.72e-06	0.000185	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CAV1—stomach cancer	7.67e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOA1—stomach cancer	7.65e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	7.53e-06	0.000181	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TYMS—stomach cancer	7.34e-06	0.000176	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.33e-06	0.000176	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTM1—stomach cancer	7.26e-06	0.000174	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALB—stomach cancer	7.15e-06	0.000172	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	6.95e-06	0.000167	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—STAT3—stomach cancer	6.89e-06	0.000165	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NOS3—stomach cancer	6.84e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ERCC2—stomach cancer	6.82e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARG—stomach cancer	6.74e-06	0.000162	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	6.58e-06	0.000158	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTHFR—stomach cancer	6.42e-06	0.000154	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MYC—stomach cancer	6.4e-06	0.000154	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	6.26e-06	0.00015	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS2—stomach cancer	6.26e-06	0.00015	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EGFR—stomach cancer	6.26e-06	0.00015	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALB—stomach cancer	6.06e-06	0.000146	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CAV1—stomach cancer	5.92e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KRAS—stomach cancer	5.91e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOA1—stomach cancer	5.9e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NOS3—stomach cancer	5.8e-06	0.000139	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	5.43e-06	0.00013	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS2—stomach cancer	5.3e-06	0.000127	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TP53—stomach cancer	5.25e-06	0.000126	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARG—stomach cancer	5.2e-06	0.000125	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HRAS—stomach cancer	5.03e-06	0.000121	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6—stomach cancer	4.81e-06	0.000115	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALB—stomach cancer	4.68e-06	0.000112	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NOS3—stomach cancer	4.47e-06	0.000107	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS2—stomach cancer	4.09e-06	9.83e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CA—stomach cancer	3.85e-06	9.25e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CA—stomach cancer	3.26e-06	7.83e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.52e-06	6.05e-05	CbGpPWpGaD
